← Open Payments lookup

LAWANDA GLASS: Open Payments

NPI 1740791722 · CLEVELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$16,064 in 158 payments from 9 companies in 2025. Trend: 2023 $2,615 · 2024 $2,791 · 2025 $16,064

Speaker / faculty: $12,796Food & beverage: $2,731Consulting: $330Education: $207
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.45$14,242
Neurocrine BioSciences, Inc.42$530
Vanda Pharmaceuticals Inc.24$404
Alkermes, Inc.14$302
ABBVIE INC.13$225
Otsuka America Pharmaceutical, Inc.9$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$98
Janssen Pharmaceuticals, Inc4$88
E.R. Squibb & Sons, L.L.C.2$35

Products named: AUSTEDO XR, INGREZZA, UZEDY, HETLIOZ, ARISTADA, VRAYLAR, ABILIFY ASIMTUFII, CAPLYTA.

Industry payments across MS — which companies pay providers there.